Bleeding Disorders
News
CHMP recommends change for eptacog alfa
The European Medicine’s Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended a change to the terms of the marketing...
News
FDA approves DNA-based blood type test
This is the first molecular-based test for red blood cell types to report genotypes in its results.
From the Journals
Genomic profiling predicts outcomes in patients with MPN
In blood cancers, there is a shift away from clinical and morphologic classification and toward genomic classification.
News
Variant not associated with CLL, AIHA, or ITP in certain patients
DUBROVNIK, CROATIA—New research suggests there is no association between the PTPN22 R620W polymorphism and chronic lymphocytic leukemia (CLL) or...
News
Emicizumab now also approved for hemophilia A without inhibitors
The U.S.
News
FDA approves emicizumab for hemophilia A without inhibitors
Emicizumab-kxwh (Hemlibra) is now approved to treat all age groups with hemophilia A, with or without factor VIII inhibitors.
From the Journals
Coagulopathy outbreak underscores danger of synthetic cannabinoids
Four patients died after developing spontaneous intracranial bleeding.
News
Product approved to treat hemophilia A in Japan
The Japanese Ministry of Health, Labour and Welfare has approved Jivi® (also known as damoctocog alfa pegol or antihemophilic factor [recombinant...
From the Journals
Eltrombopag irons out kinks in hematopoiesis
The thrombopoietin-receptor agonist’s iron-chelating action stimulates hematopoietic stem cell activity, independent of the thrombopoietin...
News
CHMP recommends factor VIII therapy for hemophilia A
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for damoctocog alfa pegol, a...
Conference Coverage
Drug-coated stent bests bare metal in patients with high bleeding risk
SAN DIEGO – Positive